WNT1 and gastric cancer: Indeed, different components of the Wnt pathway have been shown to be mutated or dysregulated in gastric cancer [21], including Wnt1 [22], SFRPs [23], Axin1 and Axin2 [24], APC [25,26], GSK3-β [27], and β-catenin [28].